Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Return on Equity (2019 - 2025)

Historic Return on Equity for 10x Genomics (TXG) over the last 7 years, with Q4 2025 value amounting to 0.06%.

  • 10x Genomics' Return on Equity rose 2000.0% to 0.06% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.06%, marking a year-over-year increase of 2000.0%. This contributed to the annual value of 0.06% for FY2025, which is 1900.0% up from last year.
  • 10x Genomics' Return on Equity amounted to 0.06% in Q4 2025, which was up 2000.0% from 0.1% recorded in Q3 2025.
  • 10x Genomics' 5-year Return on Equity high stood at 0.06% for Q4 2025, and its period low was 0.71% during Q1 2021.
  • Over the past 5 years, 10x Genomics' median Return on Equity value was 0.22% (recorded in 2025), while the average stood at 0.27%.
  • Over the last 5 years, 10x Genomics' Return on Equity had its largest YoY gain of 6200bps in 2021, and its largest YoY loss of -6000bps in 2021.
  • Over the past 5 years, 10x Genomics' Return on Equity (Quarter) stood at 0.07% in 2021, then crashed by -192bps to 0.21% in 2022, then crashed by -64bps to 0.34% in 2023, then rose by 26bps to 0.25% in 2024, then skyrocketed by 78bps to 0.06% in 2025.
  • Its Return on Equity was 0.06% in Q4 2025, compared to 0.1% in Q3 2025 and 0.11% in Q2 2025.